Deutsche Bank Ag\ Amgen Inc Call Options Transaction History

Deutsche Bank Ag\

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $60,503 - $80,244	-332 Reduced 87.37%	48 $10,000
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $309,728 - $363,071	-1,858 Reduced 83.02%	380 $70,000
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $363,729 - $410,002	2,011 Added 885.9%	2,238 $424,000
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $47,101 - $55,044	-278 Reduced 55.05%	227 $38,000
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $8,439 - $9,429	50 Added 10.99%	505 $86,000
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $76,116 - $86,905	455	455 $83,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.